NuWays reiterates BUY on Eckert & Ziegler, sets EUR 21.50 price target

Bitget2026/10/13 07:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NuWays reiterated a BUY rating on Eckert & Ziegler, setting a 12-month target price of EUR 21.50.
Report flags a valuation gap versus recent radiopharma M&A, citing implied multiples of 5.3x sales and 16x manufacturing EBITDA for ITM.
NuWays argues consolidation increases demand for independent isotope supply, positioning the company as a non-competing partner for drug developers.
Note highlights manufacturing reliability as a key differentiator, citing recent FDA setbacks tied to external manufacturing issues at peers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eckert & Ziegler SE published the original content used to generate this news brief via EQS News (Ref. ID: rc_27066) on October 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NuWays reiterates BUY on Eckert & Ziegler, sets EUR 21.50 price target

You may also like

Crypto prices